
Citnis P 500mg/800mg Tablet
Marketer
Insinius Pharmaceuticals
Salt Composition
Citicoline (500mg) + Piracetam (800mg)
Overview Citnis P 500mg/800mg Tablet
NeuroMend 500mg/800mg tablets aid in stroke recovery and cognitive enhancement. This medication safeguards brain cells from injury and promotes their repair, also finding application in brain injury treatment. NeuroMend may be ingested with or without food, ideally at the same time daily for consistent blood levels. Adhere to your physician's prescribed dosage and duration; if a dose is missed, take it immediately upon recall. Complete the entire treatment course, even with symptom improvement; abrupt cessation should be discussed with your doctor to prevent symptom exacerbation. Common, typically transient side effects include restlessness, abdominal discomfort, anxiety, and hypotension. Consult your doctor if these persist or are bothersome. Maintain adequate hydration due to potential diarrhea. Weight gain is possible; counter this with balanced nutrition and regular physical activity.
Primary Ingredients of Citnis P 500mg/800mg Tablet
No text provided to rephrase.
Uses of Citnis P 500mg/800mg Tablet
Stroke Recovery Program
Major Benefits of Citnis P 500mg/800mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Citnis P 500mg/800mg Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Citnis P 500mg/800mg Tablet:
- Weight gain
- Hyperactivity
- Stomach pain
- Nervousness
- Diarrhea
- Decreased blood pressure
- Uncoordinated body movements
- Dizziness
How to use Citnis P 500mg/800mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Citnis P 500mg/800mg tablets can be consumed with or without food, though consistent timing is recommended.
How Citnis P 500mg/800mg Tablet works:
CogniMax Duo 500mg/800mg tablets contain citicoline and piracetam, working synergistically to support neurological health. Citicoline acts as a neuroprotectant, fostering neuronal health by promoting cell survival and shielding against damage. Piracetam, a GABAergic compound, offers neuroprotection against oxygen deprivation and modulates ion channel activity within neuronal membranes.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Citnis P 500mg/800mg tablets may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Data on the use of Citnis P 500mg/800mg Tablet in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the safety of Citnis P 500mg/800mg Tablet while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving may be impaired by Citnis P 500mg/800mg Tablet, which can induce drowsiness and tremor. These side effects could negatively impact your ability to operate a vehicle.
KidneyCAUTION
Patients with impaired kidney function should exercise caution when using Citnis P 500mg/800mg tablets, as dosage modification may be necessary. A physician's consultation is advised. Citnis P 500mg/800mg tablets are contraindicated for individuals with severely compromised kidney function.
LiverSAFE IF PRESCRIBED
The use of Citnis P 500mg/800mg tablets in patients with liver disease appears to pose minimal risk. Current evidence indicates that dose modification may be unnecessary, though further data is limited. Physician consultation is advised.
What if you forget to take Citnis P 500mg/800mg Tablet :
Should you forget to take your Citnis P 500mg/800mg Tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Citnis P 500mg/800mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
